BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time - PubMed (original) (raw)
Comparative Study
BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time
Yi Luo et al. Neurobiol Dis. 2003 Oct.
Abstract
The formation of Alzheimer's Abeta peptide is initiated when the amyloid precursor protein (APP) is cleaved by the enzyme beta-secretase (BACE1); inhibition of this cleavage has been proposed as a means of treating Alzheimer's disease. (AD) We have previously shown that young BACE1 knockout mice (BACE1 KO) do not generate Abeta but in other respects appear normal. Here we have extended this analysis to include both gene expression profiling and phenotypic assessment of older BACE1 KO animals to evaluate the impact of chronic Abeta deficiency. We did not detect global compensatory changes in neural gene expression in young BACE1 KO mice. In particular, expression of the beta-secretase homolog BACE2 was not upregulated. Furthermore, we found no structural alterations in any organ, including all central and peripheral neural tissues, of BACE1 KO mice up to 14 months of age. Aged BACE1 KO mice engineered to overexpress human APP (BACE1 KO/APPtg) did not develop amyloid plaques. These data provide evidence that neither beta-secretase nor Abeta plays a vital role in mouse physiology and that chronic beta-secretase inhibition could be a useful approach in treating AD.
Similar articles
- Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
Sun X, Wang Y, Qing H, Christensen MA, Liu Y, Zhou W, Tong Y, Xiao C, Huang Y, Zhang S, Liu X, Song W. Sun X, et al. FASEB J. 2005 May;19(7):739-49. doi: 10.1096/fj.04-3426com. FASEB J. 2005. PMID: 15857888 - Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R. Zhao J, et al. J Neurosci. 2007 Apr 4;27(14):3639-49. doi: 10.1523/JNEUROSCI.4396-06.2007. J Neurosci. 2007. PMID: 17409228 Free PMC article. - Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.
Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, Zhang M, Yang Y, Cai F, Woodgett J, Song W. Ly PT, et al. J Clin Invest. 2013 Jan;123(1):224-35. doi: 10.1172/JCI64516. Epub 2012 Dec 3. J Clin Invest. 2013. PMID: 23202730 Free PMC article. - The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R. Vassar R. J Mol Neurosci. 2001 Oct;17(2):157-70. doi: 10.1385/JMN:17:2:157. J Mol Neurosci. 2001. PMID: 11816789 Review. - BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R. Vassar R. J Mol Neurosci. 2004;23(1-2):105-14. doi: 10.1385/JMN:23:1-2:105. J Mol Neurosci. 2004. PMID: 15126696 Review.
Cited by
- Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease.
Li X, Hong L, Coughlan K, Wang L, Cao L, Tang J. Li X, et al. Acta Biochim Biophys Sin (Shanghai). 2013 Aug;45(8):613-21. doi: 10.1093/abbs/gmt050. Epub 2013 May 15. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23676825 Free PMC article. Review. - Mossy fiber long-term potentiation deficits in BACE1 knock-outs can be rescued by activation of alpha7 nicotinic acetylcholine receptors.
Wang H, Song L, Lee A, Laird F, Wong PC, Lee HK. Wang H, et al. J Neurosci. 2010 Oct 13;30(41):13808-13. doi: 10.1523/JNEUROSCI.1070-10.2010. J Neurosci. 2010. PMID: 20943921 Free PMC article. - Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.
Eimer WA, Vassar R. Eimer WA, et al. Mol Neurodegener. 2013 Jan 14;8:2. doi: 10.1186/1750-1326-8-2. Mol Neurodegener. 2013. PMID: 23316765 Free PMC article. - Virtual screening and structure-based discovery of indole acylguanidines as potent β-secretase (BACE1) inhibitors.
Zou Y, Li L, Chen W, Chen T, Ma L, Wang X, Xiong B, Xu Y, Shen J. Zou Y, et al. Molecules. 2013 May 16;18(5):5706-22. doi: 10.3390/molecules18055706. Molecules. 2013. PMID: 23681056 Free PMC article. - Design and characterization of a new cell-permeant inhibitor of the beta-secretase BACE1.
Lefranc-Jullien S, Lisowski V, Hernandez JF, Martinez J, Checler F. Lefranc-Jullien S, et al. Br J Pharmacol. 2005 May;145(2):228-35. doi: 10.1038/sj.bjp.0706183. Br J Pharmacol. 2005. PMID: 15753947 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials